Alopecia areata is an autoimmune disease. People with this condition have immune systems that attack their hair follicles. This results in an inflammatory response that causes hair loss.

Alopecia areata affects millions of Americans regardless of age, race, or gender, manifesting as patchy hair loss across the scalp and sometimes other body areas. This autoimmune condition occurs ...

Alopecia areata ophiasis (hair loss in the occipital scalp region) is described to be particularly resistant to therapy, although it seldom spreads to other areas.

Alopecia areata is most common in its main form, but there are other, ... Ophiasis alopecia areata causes hair loss in a band shape around the sides and back of your head.

Alopecia areata risk also has possible positive correlations with levels of N-acetylarginine (OR, 1.31; 95% CI, 1.03-1.65; P = .025) and 12 additional serum metabolites.

The alopecia areata market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.” - The Business ...

Alopecia Universalis: Hair loss on the scalp, face, eyelashes, eyebrows, chest, and pubic areas Diffuse Alopecia Areata: Hair thinning across the entire scalp Ophiasis Alopecia: Hair loss along ...

Patchy alopecia areata causes small circular and patchy bald spots to develop, usually on the scalp and face. This is the most common type of alopecia areata, according to the NIH.

New treatment for teens with alopecia. The FDA approved the once-daily pill called Litfulo, created by pharmaceutical giant Pfizer, for people 12 and up to treat severe alopecia areata, or at ...